All the same, symptoms usually only go away completely when patients stop taking the medication
North America accounted for the largest share of the GLP-1 analogues market in 2024
If the patient isnt responding to carbohydrate administration, this generally indicates excessive insulin activity (either exogenous or endogenous)
Clinical trials show Retatrutide achieving the highest mean weight loss, followed by Tirzepatide, and then Semaglutide
Omeprazole, lisinopril, warfarin, metformin, digoxin, the combined oral contraceptive ethinyl estradiol/levonorgestrel, rosuvastatin and furosemide have all been evaluated for drug interactions with semaglutide
FDA-approved for chronic weight management and for moderate-to-severe obstructive sleep apnea in adults with obesity